Skip to main content

Imane Boutitah Benyaich

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Imane Boutitah Benyaich

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Caracterización de las infecciones y de su impacto en pacientes con Esclerosis Múltiple en la era de los tratamientos inmunosupresores de alta eficacia

IP: Susana Otero Romero
Collaborators: Imane Boutitah Benyaich, Blanca Borras Bermejo, Anna Falcó Roget, Mar Tintore Subirana, Ana Zabalza de Torres, Jesus Trejo Zahinos, Enrique Rodríguez Zafra
Funding agency: Instituto de Salud Carlos III
Funding: 115000
Reference: PI23/01654
Duration: 01/01/2024 - 31/12/2026

Related news

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Empar Francesca Moreno Penadés

Empar Francesca Moreno Penadés

Predoctoral researcher
Liver Diseases
Read more
Margarita Codinach Creus

Margarita Codinach Creus

Senior researcher
Transfusional Medicine
Read more
Blanca Gordon Ramírez

Blanca Gordon Ramírez

Main researcher
Cardiovascular Diseases
Read more
Virginia Rodríguez Garrido

Virginia Rodríguez Garrido

Predoctoral researcher
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.